Digital Podcast

Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving WBRT: First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial


Join Now to Share


ASTRO Journals show

Summary: Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving WBRT: First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial